Rifampicin Capsules Reference Listed Drug

* Please be kindly noted products are supplied for RLD supplies/ Reference listed drugs/ Comparator Drug Clinical trials. We do not sell to patients.

Name	Rifampicin Capsules
Trade name	RIFADIN
Specifications	0.15g
Dosage form	Capsules
Licensee	SANOFI AVENTIS US LLC
Remarks	The Orange Book of the United States, the name of the Orange Book of the United States: Theophylline Extended-release Tablets

This product is used in combination with other anti-tuberculosis drugs for the initial treatment and retreatment of various tuberculosis, including the treatment of tuberculous meningitis. This product is combined with other drugs for the treatment of leprosy and non-tuberculous mycobacterial infections. This product and vancomycin (intravenous) can be combined for severe infections caused by methicillin-resistant Staphylococcus. The combination of rifampicin and erythromycin is used for serious infections of Legionella. Used for asymptomatic carriers of Neisseria meningitidis to eliminate Neisseria meningitidis in the nasopharynx; but not suitable for the treatment of Neisseria meningitidis infection

We are a global professional manufacturer and supplier of reference drug products, featuring high-quality services and competitive prices. You can get the most favorable reference drug prices here. If you need customized services, please contact us immediately.

Hot Tags: Rifampicin Capsules Reference Listed Drug, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Argatroban Injection, Olanzapine Tablets, Phenytoin Sodium Tablets, Esomeprazole Magnesium Enteric Coated Capsules, Agomelatine Tablets, Acarbose Tablets

• Previous: Morphine Sulphate Sustained-release Tablets Reference Listed Drug
• Next: Lorazepam Tablets Reference Listed Drug